Druggability Evaluation Technology Platform

HomeTechnology PlatformsDruggability Evaluation Technology Platform
Back to list

Druggability Evaluation Technology Platform

The company has a comprehensive and rapid peptide druggability evaluation platform, including a peptide drug design and discovery platform, a peptide synthesis platform, systematic preclinical pharmaceutical research, pharmacodynamics research, pharmacokinetics research platforms, an SPF-grade animal facility and a GMP-standard cell facility, providing comprehensive and rapid peptide druggability evaluation.

 

 

Anji Biotech possesses various cell models;

 

 

Pharmacokinetics research: